IRINOTECAN (CPT-11) + THALIDOMIDE (THAL) IN PATIENTS (PTS) WITH ADVANCED CANCER: EVALUATION OF PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles